Estradiol Articles
Watson to acquire US rights to Columbia Labs' Crinone and Prochieve for up to $92 million
5 March 2010
Teva returns to profit, as 4th quarter 2009 sales leap 33%
16 February 2010
Bayer begins European roll-out of Qlaira
14 May 2009
Teva's 1st-qtr profit more than triples
6 May 2009
Bayer hit by charges and falling material science sales in 1st qtr, but pharma division doing well
29 April 2009
Azur launches BioSante's Elestrin in USA
16 April 2009
Teva gets FDA appro for generic Yaz
3 April 2009
Bayer must retract television adverts for Yaz to settle law suit
16 February 2009
Schering-Plough finally back in profit after Organon buy; exceeds expectations, pleasing shareholders
9 February 2009
Azur licenses US rights to Elestrin
15 January 2009
FDA approves Watson's generic Mircette
12 January 2009
Warner Chilcott and Barr settle Femcon dispute
12 January 2009
Bayer updates press on current pipeline
12 January 2009
PharmaSwiss licenses rights to BioSante's Elestrin in Israel
22 December 2008
Vivus' 3rd-qtr profit drops 79% on R&D costs
17 November 2008
Barr's LoSeasonique approved in the USA
3 November 2008
S-P profit falls 21%, still up on predictions
27 October 2008
KV to use Acrux' spray for six new products
1 September 2008
Vivus returns to profit on Evamist gain
1 September 2008
Barr's 2nd-qtr 2008 profit rises 27%
18 August 2008
BioSante reacquires Elestrin rights
18 August 2008
S-P profit down again on Organon charges
28 July 2008
Bayer enters generic Yasmin deal with Barr
30 June 2008
Stock Commentary - New York week to May 26, 2008
2 June 2008
Bayer Schering to market Yaz in EU
12 May 2008
Vivus posts $10M 4th-qtr 2007 profit
24 March 2008
Stock Commentary - New York week to March 10, 2008
17 March 2008
Stock Commentary - Europe - week to March 10, 2008
17 March 2008
US court rules patent for Yasmin is invalid
10 March 2008
Bayer's 4th-qtr 2007 profit plummets 76% to 67M euros, well below analyst expectations
10 March 2008
FDA accepts Barr's Lo Seasonique NDA
3 March 2008
S-P's 4th-qtr 2007 results hit by Organon buy
18 February 2008
Barr/Ortho OC litigation postponed
28 January 2008
FDA tightens warning on J&J's Ortho Evra patch
28 January 2008
Bayer submits new oral combo contraceptive
10 December 2007
KV reports record sales in 2nd-qtr fiscal 2008
10 December 2007
US FTC settles with Barr Labs over Ovcon
10 December 2007
Watson files ANDA for generic of Bayer-Schering's Yaz
19 November 2007
FDA clears Barr's generic Estrostep
5 November 2007
Divigel cuts menopausal symptoms
15 October 2007
Wal-Mart extends generic price cuts
15 October 2007
Watson files for generic Femcon
8 October 2007
Barr's Portia approved and launched in Canada
3 September 2007
Vivus' 2nd-qtr loss grows 16% on Qnexa costs
13 August 2007
FDA clears EvaMist for menopause symptoms
6 August 2007
Wyeth's Lybrel now on sale in USA
6 August 2007
Wyeth's 2nd-qtr net income climbs 12.5%
30 July 2007
Stock Commentary - New York week to July 23, 2007
30 July 2007
Yaz approved in the Netherlands
16 July 2007
Canada clears Seasonale OC
16 July 2007
Bradley Pharma debuts Elestrin in USA
18 June 2007
Poland
11 June 2007
Wyeth's Lybrel approved by FDA
28 May 2007
Ph IIIa NOMAC/E2 trial completes recruitment
28 May 2007
Vivus' 1st-qtr 2007 net loss narrows to $7.4M
21 May 2007
Bayer and Intendis to promote Yaz for acne
14 May 2007
BioSante gets new Elestrin formulation patent
16 April 2007
Stock Commentary - New York week to April 2
9 April 2007
KV pays initial $10M for US rights to EvaMist
9 April 2007
BioSante gets $7M milestone as FDA OKs Elestrin
2 April 2007
BioSante swings to $2.8M income in 2006
26 March 2007
Vivus' 4th-qtr 2006 net loss improves 20%
26 March 2007
Medical literature supports Bradley's low-dose estrogen
12 March 2007
Akzo Nobel's 2006 net income increases 20%
26 February 2007
Watson launches Warner Chilcott's Zenchent
5 February 2007
Yaz cleared for acne by the FDA
5 February 2007
Galapagos to buy ProSkelia for $16.5M
22 December 2006
BioSante's Elestrina cleared in the USA
22 December 2006
Vivus' EvaMist NDA accepted by US FDA
18 December 2006
First chewable birth control pill
11 December 2006
Schering AG buy boosts Bayer but charges take toll on profit; 3rd-qtr beats forecasts
4 December 2006
Generic drug antitrust settlement with US FTC
6 November 2006
Akzo's income hits 313M euro for 3rd-qtr
23 October 2006
Wyeth unveils seven late-stage drugs for 11 indications at its annual R&D presentation
16 October 2006
FDA OKs new indiction for Schering AG's YAZ
9 October 2006
Vivus files EvaMist NDA with FDA
9 October 2006
Strong Ph II data for Org 36286
2 October 2006
Warner Chilcott's 2nd-qtr losses fall 34.8%
28 August 2006
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- Elan makes "transformational" acquisitions and a divestment
- HIV vaccines: small biotech and government-funded organizations will step in where Big Pharma has fallen short, says analyst
- CIS countries prepare for the introduction of drug reimbursement schemes
- Greek research-based drugmaker group AIFD challenges generics assumptions in Draft Patent Law
